Related by context. All words. (Click for frequent words.) 69 Dyloject TM 69 POSIDUR TM 68 Valtropin 68 GW# [003] 67 Multaq dronedarone 67 RELOVAIR ™ 67 oxymorphone ER 67 phase III isavuconazole 67 SYCREST 67 GSK# [002] 67 Pivotal Phase III 67 Aceon 67 RhuDex TM 67 Clolar ® 66 phase IIb III 66 SinuNase TM 66 Benlysta belimumab 66 Proellex TM 66 Initiates Enrollment 66 Bayer Onyx 66 midstage clinical 66 MAGE A3 ASCI 66 Femara letrozole 66 YONDELIS 66 phase IIb trial 66 Aryplase 66 UPLYSO 66 Phase III Clinical Trials 66 LymphoStat B TM 66 DEB# 66 MOVIPREP R 66 Proquin XR 66 including eniluracil ADH 65 budesonide foam 65 Milnacipran 65 Vertex hepatitis C 65 SILENOR 65 Pazopanib 65 Frova ® 65 Initiates Phase III 65 Zometa zoledronic acid 65 IL# PE#QQR 65 Deferiprone 65 Ereska 65 pregabalin Lyrica 65 Omnaris 65 reslizumab 65 thalidomide Thalomid 65 SPRYCEL ® 65 diabetic neuropathic pain 65 Tykerb lapatinib 65 intranasal formulation 65 Achieves Primary Endpoint 65 novel oral anticoagulant 65 Initiates Clinical Trial 65 nasal formulation 65 TLK# 65 OvaRex ® MAb 65 Completes Patient Enrollment 65 Stedesa 65 injectable formulations 65 Raptiva ® 65 aripiprazole Abilify 65 PrevOnco 65 MKC# MT 65 Modrenal R 65 BRILINTA 65 ularitide 65 PF # [002] 65 Successfully Completes Phase 65 CDP# 65 Tarceva TM 65 Pafuramidine 65 Evoltra ® 65 Phase IIA 65 incyclinide 65 receptor tyrosine kinase inhibitor 65 FOLOTYN ® 65 cannabinor 65 injectable diclofenac 65 Iloperidone 65 Cloretazine ® 64 RhuDex 64 Serdolect ® 64 Phase 2b Clinical Trial 64 micafungin 64 Pimavanserin 64 regorafenib 64 topical NSAID 64 Brilique 64 LEVADEX ™ 64 Oracea ® 64 adenosine injection 64 Febuxostat 64 pioglitazone hydrochloride 64 Phase IIIb clinical 64 Civacir 64 ZOLINZA 64 clevidipine 64 Phase IIb clinical trials 64 gepirone ER 64 Cancidas 64 Ceflatonin R 64 bicifadine 64 trastuzumab DM1 64 Aflibercept 64 Firazyr 64 Phase IIb III 64 TRISENOX R 64 acyclovir Lauriad R 64 COLAL PRED 64 elotuzumab 64 randomized Phase IIb 64 hypoxia activated prodrug 64 CAELYX 64 OVATURE 64 Corlux 64 dextofisopam 64 Anidulafungin 64 AZILECT R 64 galiximab 64 etanercept Enbrel 64 Mesafem 64 Phase 2b clinical trials 64 forodesine 64 ACOMPLIA R 64 OvaRex 64 Omnitarg 64 PANVAC VF 64 JAK inhibitor 64 Noxafil 64 initiated Phase Ib 64 Receives Approvable Letter 64 MAA submission 64 Phase #b/#a clinical 64 phase IIb clinical 63 anti inflammatory NSAID 63 Initiates Clinical 63 Phase 1b trial 63 Raptiva R 63 IMA# 63 Panzem R NCD 63 phase IIa clinical 63 Allovectin 7 63 gets USFDA nod 63 Cinquil 63 OncoVex 63 Dacogen injection 63 Silenor ® 63 Retacrit 63 investigational protease inhibitor 63 mertansine 63 Marketing Authorisation Application 63 Initiates Phase 2b 63 rufinamide 63 Phase III Trials 63 ZACTIMA 63 SNT MC# 63 Fludara ® 63 Zenpep 63 lumiliximab 63 Elagolix 63 Gleevec Glivec 63 LUMINATE 63 Zoraxel 63 Danazol 63 Personalized Immunotherapy 63 SAR# [004] 63 YONDELIS R 63 buccal spray 63 Ciclesonide 63 Prosaptide 63 Ixempra 63 Eraxis 63 glucokinase activator 63 rasagiline tablets 63 albiglutide 63 hoFH 63 Oncogenex 63 IV Busulfex 63 phase IIb study 63 beta 1a 63 lenalidomide Revlimid 63 EOquin TM 63 Navelbine ® 63 Vectibix panitumumab 63 AstraZeneca Symbicort 63 ORENCIA ® 63 Oasmia 63 histamine dihydrochloride 63 KRN# 63 Phase III Clinical Trial 63 Commences Phase III 63 Orally administered 63 orBec 63 IV acetaminophen 63 Pirespa 63 Bicifadine 63 IIa trials 63 Desvenlafaxine 63 Daclizumab 63 oral salmon calcitonin 63 midstage trials 63 Plenaxis TM 63 RhuDex ® 63 Pertuzumab 63 desvenlafaxine 63 vaginally administered lidocaine 63 Vidaza azacitidine 63 aerosolized AAT 63 Velcade bortezomib 63 Troxatyl 63 pharmacokinetic PK study 63 Meets Primary Endpoint 63 phase IIa 63 Kissei Pharmaceutical 63 inhaled AAT 63 Pemetrexed 63 Combination REOLYSIN R 63 Hedgehog antagonist 62 evaluating mipomersen 62 omacetaxine mepesuccinate 62 UCB Cimzia 62 MGN# 62 Temsirolimus 62 Lupuzor 62 oral ridaforolimus 62 Silodosin 62 balsalazide tablet 62 Initiates Phase II 62 Posidur 62 guanfacine extended release 62 Mycophenolate Mofetil 62 Trobalt 62 phase IIb 62 Reverset 62 Tocosol 62 Roche Xeloda 62 Teysuno 62 ruxolitinib 62 Pirfenidone 62 CytoFabTM 62 Dacogen decitabine 62 HCl capsules 62 compound INCB# 62 Presents Positive Preclinical 62 Fabry Disease 62 Aurexis 62 Phase Ib II 62 immunotherapeutic vaccine 62 phase IIIb 62 Oglemilast 62 Quinamed 62 adalimumab Humira 62 Voraxaze 62 Efficacy Trial 62 PDX pralatrexate 62 Riluzole 62 Phase IIb trials 62 PROSTVAC ® 62 ospemifene 62 intravenous acetaminophen 62 Antiarrhythmic 62 Cetrorelix 62 successfully commercialize Iluvien 62 Fulvestrant 62 midstage studies 62 thetreatment 62 PREOS R 62 Etravirine 62 LUNESTA ® 62 candidate TNFerade biologic 62 Albugon 62 Entocort 62 AMEVIVE 62 R sorafenib tablets 62 THALOMID 62 Clofarabine 62 LibiGel ® 62 BARACLUDE R 62 Sporanox 62 Xyrem ® 62 BLA filing 62 baminercept 62 vinorelbine tartrate 62 Targretin capsules 62 Ambrisentan 62 docetaxel Taxotere R 62 Phase #b/#a 62 Phase IIb Trial 62 phase Ib 62 Zemplar Capsules 62 relapsed MM 62 Vimpat lacosamide 62 OvaRex R 62 SNT-MC#/idebenone 62 compound KOS 62 Nexavar sorafenib 62 Daptomycin 62 recurrent herpes labialis 62 selective estrogen receptor modulator 62 retinal vein occlusion induced 62 SAR# [002] 62 Soliris TM eculizumab 62 Fosphenytoin 62 alemtuzumab Campath 62 docetaxel Taxotere ® 62 Files IND 62 Submits NDA 62 SUTENT ® 62 Japanese Encephalitis vaccine 62 Patients Treated With 62 Urocidin 62 Ganciclovir 62 abatacept Orencia 62 huC# DM4 62 Sebivo 62 Revlimid lenalidomide 62 RH1 62 ThermoDox R 62 Cimzia TM 62 Huntexil 62 Xifaxan rifaximin 62 Eli Lilly Cymbalta 62 miconazole Lauriad ® 62 Phase IIB 62 Valdoxan 62 Fondaparinux 62 beta interferons 62 severe hypercholesterolemia 62 Lyrica pregabalin 62 BRAF inhibitor 62 TASKi3 62 BRIM3 62 Somatuline Autogel 62 erlotinib Tarceva ® 62 Xanafide 62 sunitinib malate 62 sertraline Zoloft 62 Betaferon R 62 Tocosol Paclitaxel 62 Joulferon 62 Auxilium Pharma 62 Vidaza R 62 TransMID 62 Drug Eluting Stent System 62 vismodegib 61 sorafenib tablets 61 Sustiva efavirenz 61 Eloxatin ® 61 INS# [001] 61 RSR# 61 Increlex R 61 vemurafenib 61 Interferon Alpha 61 Tarceva erlotinib 61 tramiprosate Alzhemed TM 61 Tesmilifene 61 TRISENOX 61 antihormonal 61 Preotact 61 docetaxel Taxotere 61 neratinib 61 intravenous AAT 61 Equetro 61 Plicera 61 Zyflo 61 Safinamide 61 nalbuphine ER 61 Glatiramer Acetate 61 EDEMA3 61 tubulin inhibitor 61 trastuzumab DM1 T DM1 61 Ozarelix 61 Marketing Authorization Applications 61 Cerimon 61 bortezomib Velcade 61 BENLYSTA ® 61 Gleevec imatinib mesylate 61 Gilead Viread 61 Archexin 61 Removab 61 Muraglitazar 61 Zemiva TM 61 Romiplostim 61 rALLy 61 oral PTH 61 AstraZeneca Iressa 61 FUSILEV ® 61 HepeX B TM 61 OMAPRO ™ 61 prucalopride 61 FIRMAGON R 61 sitaxsentan 61 Cleviprex TM clevidipine 61 FDA Approvals 61 EpiCeram 61 Glycopyrrolate 61 Trastuzumab DM1 61 HP Acthar R 61 Gelclair 61 Simulect 61 Clevudine 61 Nivestim 61 Vitaxin 61 Mycamine 61 tipifarnib 61 evaluating tivozanib 61 interferon gamma 1b 61 Movectro 61 Kamada AAT 61 torezolid phosphate 61 Annamycin 61 Plaquenil 61 Catena ® 61 Mipomersen 61 TRANSDUR Sufentanil 61 Presents Positive 61 oral prodrug 61 ZEVALIN ® 61 treat enlarged prostate 61 Seroquel quetiapine fumarate 61 Frova R 61 Androgel R 61 Monopril 61 Fibrillex 61 TASKi2 61 Factor VIIa 61 oxypurinol 61 Adentri 61 herpetic keratitis 61 non nucleoside inhibitor 61 Triapine 61 gefitinib Iressa 61 Roflumilast 61 Somatuline R Depot 61 Pivotal Clinical Trial 61 Certican 61 Alvesco R 61 alvespimycin 61 Onalta ™ 61 SPL# Gel vaginal microbicide 61 Iluvien TM 61 fluvastatin 61 glatiramer 61 Advagraf 61 enoxaparin Lovenox 61 Tracleer r 61 Bosutinib 61 Campath ® 61 Nexavar ® 61 Rezonic 61 initiate Phase IIa 61 Rhucin ® recombinant 61 Octreotide 61 DDP# 61 Vimpat ® lacosamide 61 lorvotuzumab mertansine 61 Egrifta 61 Mirapexin 61 Hyphanox 61 Ceflatonin 61 CRMD# 61 Oracea TM 61 Fesoterodine 61 Telithromycin 61 TEMSO 61 Plenaxis R 61 Genentech Rituxan 61 fostamatinib 61 Abilify aripiprazole 61 Zybrestat 61 Ophena TM 61 BrachySil TM 61 teriflunomide 61 Aplidin 61 Remicade infliximab 61 Pfizer Camptosar 61 Saforis 61 REMOXY ® 61 Orencia abatacept 61 indiplon capsules 61 Myocet 61 Actimmune ® 61 Levetiracetam 61 lomitapide 61 INSPIRE Trial Phase III 61 Drug Fails 61 Fenoglide 61 cancer neuroendocrine tumor 61 cetuximab Erbitux 61 Anturol TM 61 Tostran 61 mitoxantrone plus 61 Pfizer Sutent 61 CRLX# 61 PEG IFN 61 midstage clinical trials 61 Onconase 61 Fodosine 61 amrubicin 61 rilonacept 61 Potiga 61 Tofacitinib 61 HepeX B 61 Fortigel 61 Vicriviroc 61 Geodon ziprasidone 61 RezularTM 61 Receives Positive Opinion 61 eosinophilic asthma 61 GLP toxicology studies 61 APTIVUS 61 INVEGA ® SUSTENNA ® 61 humanised monoclonal antibody 61 Known generically 61 Nebido 61 Toremifene 61 Panzem NCD 61 GlaxoSmithKline Requip 61 inhalation aerosol 61 LymphoStat B belimumab 61 ITAX 61 Wellstat 61 FDA Approvable Letter 61 CONBRIZA 61 Cloretazine 61 hyaluronidase enzyme 61 Bifeprunox 61 deforolimus 61 pemetrexed Alimta 61 INVEGA ® 61 orally inhaled migraine 61 Commences Phase 61 outlicensed 61 Contrave# 61 riociguat 61 recombinant biopharmaceutical 61 Solorel ® 60 Requip XL 60 Pyridorin 60 Sanofi Aventis Taxotere 60 Panzem R 60 eribulin mesylate 60 Trandolapril 60 VEGF inhibitor 60 Sycrest 60 Prandin 60 canakinumab 60 Peginterferon alfa 2b 60 Fingolimod 60 ARIXTRA R 60 LEUKINE 60 Xolegel 60 Announces Tentative Approval 60 JAK Inhibitor 60 HoFH 60 Neuvenge 60 Ramelteon 60 PDE4 inhibitor 60 LUNESTA TM 60 aclidinium 60 serotonin norepinephrine reuptake inhibitor 60 Pixuvri 60 Amrubicin 60 epigenetic therapies 60 XIENCE V Stent System 60 Renal Cell Carcinoma RCC 60 OMNARIS HFA 60 Testosterone MDTS ® 60 Celgene Thalomid 60 Tasimelteon 60 Irinotecan 60 Tanespimycin 60 Launches Generic Version 60 Drug Candidate 60 IV APAP 60 Combunox 60 intravenous formulations 60 omega interferon 60 inhibit EGFR 60 Bazedoxifene 60 Bayer Nexavar 60 ALVESCO R 60 evaluating REVLIMID 60 L BLP# 60 Triapine R 60 EGS# 60 bosutinib 60 Golimumab 60 REBETOL combination therapy 60 briakinumab 60 Orapred ODT 60 Presents Preclinical Data 60 Itopride 60 orally disintegrating formulation 60 Flutiform TM 60 Oral Insulin Capsule 60 OHR/AVR# 60 trastuzumab Herceptin R 60 AVASTIN 60 Evoltra 60 Phase 2a Trial 60 acyclovir Lauriad ® 60 panitumumab Vectibix 60 Orphan Status 60 Tibotec Pharmaceuticals Ltd. 60 BLP# Liposome Vaccine 60 Aliskiren 60 ORENCIA R 60 Emselex 60 Perforomist ™ Inhalation Solution 60 multicenter Phase II 60 granulated mesalamine 60 orally disintegrating 60 luliconazole 60 Xcytrin R 60 Phase IIa trials 60 ADP receptor antagonist 60 Pivotal Study 60 Pagoclone 60 Licenses Novel 60 Dalbavancin 60 Copegus ribavirin 60 sorafenib Nexavar 60 tolevamer 60 rALLy trial 60 Bicalutamide 60 Cymbalta duloxetine 60 Multiple Ascending Dose 60 Serdolect 60 anastrozole Arimidex 60 CINTREDEKIN BESUDOTOX 60 paroxetine Seroxat 60 Olmesartan 60 Intravitreal 60 Levoleucovorin 60 ImClone Erbitux 60 refractory APL 60 AEGR 60 Pancreas Cancer Vaccine 60 Sutent sunitinib 60 IND Investigational New 60 Fast Track Status 60 Vertex telaprevir 60 SPARLON 60 Ketotransdel 60 Romidepsin 60 AzaSite Plus 60 #mg/#mg 60 Hsp# Inhibitor 60 Squalamine 60 Gemzar gemcitabine 60 Alemtuzumab 60 Aplenzin 60 Neovastat 60 nucleotide analogue 60 Accolate 60 #mg Tablets [002] 60 Celgene Revlimid 60 Liprotamase 60 Bayer HealthCare Onyx Pharmaceuticals 60 Marqibo TM 60 Icatibant 60 Zenvia ™ 60 Telintra 60 nalmefene 60 Presents Preclinical 60 HepaGam B R 60 Degarelix 60 Sprycel dasatinib 60 EVIZON TM 60 EP #R 60 Phase III Trial 60 Fluticasone 60 Afatinib 60 alefacept 60 Bristol Myers Squibb Pravachol 60 Tekturna HCT 60 Exherin TM 60 Asmanex 60 NV1FGF 60 Phase IIIb 60 zileuton CR 60 Initiate Phase 60 candidate CRLX# 60 candidate AQ4N 60 quinolone antibiotic 60 Pivotal Trial 60 Androxal TM 60 Fluconazole 60 Spiegelmer ® 60 Forodesine HCl 60 tamoxifen citrate 60 adipiplon 60 Cellegesic 60 TELINTRA 60 phase 2a 60 DURIN TM 60 vidofludimus 60 dexanabinol 60 VNP#M 60 fluoroquinolone antibiotic 60 TNFerade TM 60 rEV# 60 Onco TCS 60 Insegia 60 investigational antiplatelet agent 60 Botox Botox Cosmetic 60 myelodysplastic myeloproliferative diseases 60 GRN# 60 Investigational Treatment 60 Orazol 60 Phase Ib clinical 60 virus HCV protease inhibitor 60 DPX Survivac 60 Torisel temsirolimus 60 AZILECT ® 60 SEPET TM 60 Pivotal Phase 60 Clonicel 60 cromolyn sodium 60 www.soliris.net 60 assessing T DM1 60 Syndax Pharmaceuticals Inc. 60 nanopharmaceutical 60 Darusentan 60 omiganan 60 ATL# [001] 60 Phase Ib study 60 Ticagrelor 60 miconazole Lauriad R 60 non nucleoside HCV 60 Biogen Avonex 60 Aptivus 60 RECOTHROM R 60 Tacrolimus 60 BEMA TM LA 60 Ziprasidone 60 refractory chronic lymphocytic 60 MEVACOR 60 APTIMA HPV assay 60 LCP AtorFen 60 cardio renal 60 QNEXA ® 60 Phase Ib IIa 60 generation purine nucleoside 60 urocortin 2 60 Angiox 60 topical ocular 60 antibody MAb 60 CIP TRAMADOL ER 60 CYCLOSET 60 Ridaforolimus 60 velafermin 60 enoxaparin sodium injection 60 Omigard TM 60 LAS# [002] 60 dextromethorphan quinidine 60 GALNS 60 CINQUIL 60 PRIALT 60 Phase 2a clinical trials 60 NSABP B 60 oral rivaroxaban 60 Singulair montelukast 60 NP2 Enkephalin 60 biliary tract cancer 60 SUPPRELIN R LA 60 CHAMPION PCI 60 transgenically produced product 60 TBC# 60 ixabepilone 60 Finacea 60 PEGylated interferon beta 1a 60 PARP Inhibitor 60 Gabapentin GR 60 Demonstrates Efficacy 60 tipranavir 60 Zavesca r 60 BioNumerik 60 generation URAT1 inhibitor 60 Kynapid 60 ONGLYZA ™ 60 Effexor venlafaxine 60 Wyeth Enbrel 60 Junovan TM 60 Phase IIa trial 60 Efient 60 Serada 60 octreotide implant 60 Onrigin 60 Gaboxadol 60 Tenofovir DF 60 Medidur TM FA 60 donepezil rivastigmine 60 Voraxaze ™ 60 Teriflunomide 60 vernakalant hydrochloride 60 visilizumab 60 PDE# inhibitors 60 perampanel 60 Viramidine 60 Omacor ® 60 RTP #i 60 BEMA TM Fentanyl 60 Generic Versions 59 refractory metastatic colorectal cancer 59 UCB Keppra 59 Gralise 59 molecular imaging radiopharmaceutical 59 pertuzumab 59 mapatumumab 59 BR.# 59 Myelodysplastic Syndrome MDS 59 Phase IIIb study 59 varenicline tartrate 59 Seattle Genetics SGEN 59 oral taxane 59 ONCONASE R 59 Xarelto rivaroxaban 59 LSE ASM 59 Omapro 59 Brinavess 59 Xelox 59 TMC# [002] 59 refractory CLL 59 Teflaro 59 brivaracetam 59 JOULFERON 59 Phase 1b clinical trials 59 Evoltra TM 59 BiDil XR 59 Hematide ™ peginesatide 59 STELARA TM 59 Dabigatran etexilate 59 sublingual tablets 59 methylnaltrexone bromide 59 Montelukast 59 Urocortin 2 59 Paxil paroxetine 59 olanzapine Zyprexa 59 Latuda 59 PI3K/Akt pathway inhibitor 59 BRIM2 59 refractory gout 59 trospium chloride 59 Galantamine 59 adjuvant colon cancer 59 Bioral Amphotericin B 59 Mepact 59 REMINYL ® 59 PREVU * POC 59 Circ Pharma 59 Motavizumab 59 HIV integrase inhibitor 59 ® lenalidomide 59 HCV RESPOND 2 59 vinflunine 59 Psoriasis Drug 59 LEP ETU 59 Zoloft sertraline 59 ticagrelor Brilinta 59 Uvidem 59 proteasome inhibitor 59 Product Monograph 59 Oxaliplatin 59 senicapoc 59 PHX# 59 GEM OS2 59 NSABP C 59 Phase IIb Clinical Trial 59 preclinical efficacy 59 DP VPA 59 DNAwithPap TM Test 59 forodesine hydrochloride 59 Diamyd ® 59 BrachySil 59 PSN# [002] 59 fosbretabulin 59 IIa trial 59 nucleoside analogs 59 labial herpes 59 Alinia 59 mesylate 59 Afinitor everolimus 59 Akt inhibitor 59 Roche Actemra 59 Entecavir 59 tiapamil 59 Investigational Compound 59 rheumatoid arthritis psoriatic arthritis 59 Topical Gel 59 bardoxolone 59 sodium thiosulfate STS 59 DPP4 inhibitor 59 Amlodipine Besylate 59 lamotrigine Lamictal 59 opioid naive 59 ATryn ® 59 Erbitux cetuximab 59 ICA # 59 Emtriva emtricitabine 59 lexidronam injection 59 AMITIZA ® 59 Anti VEGF 59 Berinert 59 alvimopan 59 Rilutek 59 Zyflo CR 59 rosiglitazone maleate 59 eritoran 59 prasugrel Effient 59 Cellcept 59 bazedoxifene 59 Intervention Effectiveness 59 5 lipoxygenase inhibitor 59 Prilosec omeprazole 59 Somatuline Depot 59 Risperidone Oral Solution 59 mycophenolate mofetil MMF 59 AERIUS 59 TheraCIM 59 BEMA Buprenorphine 59 Tredaptive 59 telomerase therapeutic 59 faropenem 59 Hormone Refractory Prostate Cancer 59 Pharmacokinetics PK 59 advanced medullary thyroid 59 Shigamabs ® 59 Onsolis 59 Indomethacin 59 Nutra Pharma wholly owned 59 Shows Efficacy 59 Diamyd R 59 NB S# strontium malonate 59 ANTEGREN 59 MS spasticity 59 CELVAPAN H#N# 59 MCSP respectively 59 Rasagiline 59 Matrix Phase 2b 59 Allovectin 7 ® 59 ZEFTERA TM Zevtera TM 59 Tamsulosin 59 Vivecon 59 silodosin 59 Dasatinib 59 Avonex interferon beta 1a 59 partner ECR Pharmaceuticals 59 Actemra tocilizumab 59 Intuniv 59 Capesaris 59 PROTONIX 59 Sanvar 59 ritonavir boosted 59 Phase III multicenter 59 Clinical Trial Results 59 efalizumab 59 faropenem medoxomil 59 Phase III ADT 59 Dendreon Provenge 59 treatmentof 59 dalbavancin 59 Almorexant 59 IIa Clinical Trial 59 pain palliation 59 escitalopram oxalate 59 AGGRASTAT ® tirofiban hydrochloride 59 paroxetine Paxil 59 Stalevo ® 59 Nabi HB Intravenous 59 highly selective inhibitor 59 targeted radiotherapeutic 59 Eltrombopag 59 Preos 59 SYN# 59 Zavesca 59 Neulasta ® 59 Iressa gefitinib 59 Ceplene TM 59 Onglyza saxagliptin 59 FASLODEX 59 Panzem 59 Pentasa 59 Alimta pemetrexed 59 investigational humanized monoclonal antibody 59 catheter occlusion 59 ponatinib 59 Glybera R 59 POSIDUR TM ELADUR TM 59 Intravenous Formulation 59 MabThera rituximab 59 propranolol Inderal 59 Focalin XR 59 HCV polymerase 59 Stavzor 59 Phase 1a clinical